Login / Signup
Clinicopathologic consequences following discontinuation of rifaximin in patients with sickle cell disease.
Matthew J Lim
Dibyendu Dutta
Published in:
American journal of hematology (2020)
Keyphrases
</>
end stage renal disease
ejection fraction
newly diagnosed
prognostic factors